Equities research analysts expect Monsanto Company (NYSE:MON) to announce earnings per share (EPS) of ($0.38) for the current quarter, Zacks reports. Two analysts have provided estimates for Monsanto’s earnings, with estimates ranging from ($0.47) to ($0.22). Monsanto reported earnings of $0.07 per share during the same quarter last year, which suggests a negative year-over-year growth rate of 642.9%. The business is scheduled to announce its next earnings results before the market opens on Wednesday, October 4th.

According to Zacks, analysts expect that Monsanto will report full year earnings of $4.95 per share for the current financial year, with EPS estimates ranging from $4.85 to $5.10. For the next financial year, analysts forecast that the business will report earnings of $5.36 per share, with EPS estimates ranging from $5.05 to $5.60. Zacks’ EPS averages are a mean average based on a survey of analysts that cover Monsanto.

Monsanto (NYSE:MON) last announced its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. During the same quarter in the prior year, the company earned $2.17 EPS. The business’s revenue was up 1.0% compared to the same quarter last year.

A number of brokerages recently issued reports on MON. UBS AG lowered Monsanto from a “positive” rating to a “neutral” rating in a report on Tuesday, June 27th. Jefferies Group LLC lowered Monsanto from a “buy” rating to a “hold” rating and set a $128.00 price target for the company. in a report on Wednesday, July 12th. Citigroup Inc. reiterated a “neutral” rating and issued a $126.00 price target (up previously from $125.00) on shares of Monsanto in a report on Monday, July 10th. Vetr raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective for the company in a research note on Wednesday, July 12th. Finally, Barclays PLC boosted their price objective on shares of Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 29th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and nine have issued a buy rating to the company’s stock. Monsanto currently has a consensus rating of “Hold” and a consensus target price of $123.15.

In related news, SVP Janet M. Holloway sold 3,337 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $118.00, for a total value of $393,766.00. Following the transaction, the senior vice president now directly owns 44,405 shares of the company’s stock, valued at approximately $5,239,790. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Steven Mizell sold 11,300 shares of the company’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the completion of the transaction, the executive vice president now directly owns 55,011 shares in the company, valued at $6,522,654.27. The disclosure for this sale can be found here. Over the last three months, insiders sold 85,816 shares of company stock worth $10,117,174. 0.79% of the stock is owned by insiders.

Institutional investors have recently added to or reduced their stakes in the stock. HighPoint Advisor Group LLC increased its position in Monsanto by 11.4% in the fourth quarter. HighPoint Advisor Group LLC now owns 2,472 shares of the basic materials company’s stock valued at $286,000 after buying an additional 253 shares during the last quarter. Israel Discount Bank of New York GFN purchased a new position in Monsanto during the fourth quarter valued at about $140,000. Norges Bank purchased a new position in Monsanto during the fourth quarter valued at about $406,735,000. Sowell Financial Services LLC purchased a new position in Monsanto during the fourth quarter valued at about $480,000. Finally, Luminus Management LLC purchased a new position in Monsanto during the fourth quarter valued at about $14,596,000. 74.87% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Monsanto (NYSE:MON) traded up 0.68% on Friday, hitting $117.46. The stock had a trading volume of 1,361,124 shares. Monsanto has a 52-week low of $97.35 and a 52-week high of $118.97. The company has a market cap of $51.60 billion, a P/E ratio of 25.37 and a beta of 1.08. The company has a 50-day moving average of $117.60 and a 200-day moving average of $114.01.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Investors of record on Friday, July 7th will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. The ex-dividend date of this dividend is Wednesday, July 5th. Monsanto’s payout ratio is 46.75%.

WARNING: This story was first posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.watchlistnews.com/0-38-earnings-per-share-expected-for-monsanto-company-mon-this-quarter/1453651.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Get a free copy of the Zacks research report on Monsanto (MON)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.